1. Home
  2. SEER

as of 02-27-2026 3:41pm EST

$1.75
$0.33
-16.11%
Stocks Health Care Medicinal Chemicals and Botanical Products Nasdaq

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.

Founded: 2017 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 111.4M IPO Year: 2020
Target Price: N/A AVG Volume (30 days): 348.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: semi-annual
EPS: -1.02 EPS Growth: 9.40
52 Week Low/High: $1.62 - $2.41 Next Earning Date: 05-29-2026
Revenue: $14,170,000 Revenue Growth: -14.95%
Revenue Growth (this year): 22.37% Revenue Growth (next year): 30.00%
P/E Ratio: -2.03 Index: N/A
Free Cash Flow: -49693000.0 FCF Growth: N/A

AI-Powered SEER Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 68.55%
68.55%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Seer Inc. (SEER)

Farokhzad Omid

CEO AND CHAIR

Sell
SEER Feb 18, 2026

Avg Cost/Share

$1.99

Shares

24,385

Total Value

$48,645.64

Owned After

3,349,064

SEC Form 4

Horn David R.

PRESIDENT & CFO

Sell
SEER Feb 18, 2026

Avg Cost/Share

$1.99

Shares

7,743

Total Value

$15,446.51

Owned After

501,262

SEC Form 4

Share on Social Networks: